NCT04753164: A reported trial by Idorsia Pharmaceuticals Ltd.
This trial has reported on time, in line with the regulations.
Full data
Full entry on ClinicalTrials.gov | NCT04753164 |
---|---|
Title | Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Proof-of-concept Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder |
Results Status | Reported |
ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
Start date | Feb. 16, 2021 |
Completion date | March 21, 2022 |
Required reporting date | March 21, 2023, midnight |
Actual reporting date | March 6, 2023 |
Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
Days late | None |